Charles River and Takeda Announce Collaboration

Published on: 

Applied Clinical Trials

Charles River has announced a multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited. Together they will launch multiple integrated programs across Takeda’s four core therapeutic areas with the ultimate goal of delivering preclinical candidates that Takeda can advance into clinical development. 

For more information on this collaboration, click here.